Leeward Investments LLC MA Sells 9,158 Shares of Humana Inc. (NYSE:HUM)

Leeward Investments LLC MA lessened its holdings in Humana Inc. (NYSE:HUM) by 20.6% during the 3rd quarter, Holdings Channel.com reports. The firm owned 35,315 shares of the insurance provider’s stock after selling 9,158 shares during the period. Leeward Investments LLC MA’s holdings in Humana were worth $11,186,000 as of its most recent filing with the Securities & Exchange Commission.

A number of other institutional investors and hedge funds also recently made changes to their positions in the business. Norden Group LLC boosted its position in shares of Humana by 137.9% in the first quarter. Norden Group LLC now owns 1,130 shares of the insurance provider’s stock worth $392,000 after purchasing an additional 655 shares during the period. Leith Wheeler Investment Counsel Ltd. bought a new position in shares of Humana in the first quarter worth about $12,607,000. Duality Advisers LP boosted its stake in shares of Humana by 58.3% in the first quarter. Duality Advisers LP now owns 19,182 shares of the insurance provider’s stock worth $6,651,000 after acquiring an additional 7,068 shares during the period. Empirical Finance LLC grew its position in shares of Humana by 3.4% during the first quarter. Empirical Finance LLC now owns 4,543 shares of the insurance provider’s stock worth $1,575,000 after purchasing an additional 148 shares in the last quarter. Finally, Envestnet Portfolio Solutions Inc. raised its stake in Humana by 137.6% during the 1st quarter. Envestnet Portfolio Solutions Inc. now owns 4,801 shares of the insurance provider’s stock valued at $1,665,000 after purchasing an additional 2,780 shares during the period. Hedge funds and other institutional investors own 92.38% of the company’s stock.

Wall Street Analyst Weigh In

A number of equities research analysts have issued reports on HUM shares. Oppenheimer cut their price objective on shares of Humana from $400.00 to $280.00 and set an “outperform” rating for the company in a report on Thursday, October 3rd. Bank of America raised shares of Humana from an “underperform” rating to a “neutral” rating and raised their target price for the company from $247.00 to $308.00 in a research note on Wednesday. JPMorgan Chase & Co. increased their price objective on shares of Humana from $332.00 to $396.00 and gave the company a “neutral” rating in a report on Wednesday, August 21st. Sanford C. Bernstein raised Humana from a “market perform” rating to an “outperform” rating and set a $308.00 price target for the company in a research note on Tuesday, October 8th. Finally, UBS Group reduced their price objective on Humana from $380.00 to $250.00 and set a “neutral” rating on the stock in a research note on Friday, October 4th. Twenty analysts have rated the stock with a hold rating and six have given a buy rating to the stock. Based on data from MarketBeat, the company has an average rating of “Hold” and an average price target of $315.86.

Humana Trading Up 10.8 %

NYSE HUM opened at $288.69 on Thursday. Humana Inc. has a 12 month low of $213.31 and a 12 month high of $527.18. The company’s 50-day moving average price is $291.98 and its 200-day moving average price is $333.24. The stock has a market cap of $34.76 billion, a PE ratio of 25.57, a PEG ratio of 1.98 and a beta of 0.52. The company has a current ratio of 1.76, a quick ratio of 1.76 and a debt-to-equity ratio of 0.67.

Humana (NYSE:HUM) last issued its earnings results on Wednesday, October 30th. The insurance provider reported $4.16 EPS for the quarter, topping analysts’ consensus estimates of $3.48 by $0.68. The business had revenue of $29.30 billion for the quarter, compared to analyst estimates of $28.66 billion. Humana had a net margin of 1.18% and a return on equity of 13.20%. Equities research analysts forecast that Humana Inc. will post 16.15 earnings per share for the current year.

Humana Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, January 31st. Stockholders of record on Tuesday, December 31st will be paid a dividend of $0.885 per share. The ex-dividend date of this dividend is Tuesday, December 31st. This represents a $3.54 annualized dividend and a dividend yield of 1.23%. Humana’s dividend payout ratio is currently 31.36%.

Humana Profile

Humana Inc, together with its subsidiaries, provides medical and specialty insurance products in the United States. It operates through two segments, Insurance and CenterWell. The company offers medical and supplemental benefit plans to individuals. It has a contract with Centers for Medicare and Medicaid Services to administer the Limited Income Newly Eligible Transition prescription drug plan program; and contracts with various states to provide Medicaid, dual eligible, and long-term support services benefits.